Yes. Aripiprazole is one of the 76 compounds in the LabX LC-MS/MS confirmation panel, reported as detected at or above 40 ng/mL. Aripiprazole is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
Aripiprazole is an atypical (second-generation) antipsychotic medicine.
Also known as or found in: Abilify.
Aripiprazole is prescribed for schizophrenia, bipolar disorder, as an add-on treatment for depression, and for some other conditions.
Aripiprazole is measured by liquid chromatography with tandem mass spectrometry (LC-MS/MS), which separates the compounds in a sample and identifies each one by its mass. That is different from a rapid screen, which reacts to a family of drugs and can occasionally react to a related substance. The laboratory reports Aripiprazole as detected when its concentration is at or above the cut-off of 40 ng/mL, within a reportable range of 40–1,600 ng/mL. It is one of 6 compounds in the antipsychotics and mood family on the 76-drug confirmation panel.
The laboratory's confirmation report does not print a standard detection window for Aripiprazole. How long any compound stays measurable varies with the amount taken, how often it is used, metabolism and hydration, and a laboratory result cannot be used to work out when a substance was taken.
Aripiprazole is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
Antipsychotic medicines are identified by laboratory confirmation when a clinician needs to know what is present, for example to review a medication list.
Medicines prescribed for psychiatric conditions and anxiety, identified by confirmation when a medication list needs to be checked.
Yes. Aripiprazole is one of the 76 compounds in the LabX LC-MS/MS confirmation panel, reported as detected at or above 40 ng/mL. Aripiprazole is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
LabX reports Aripiprazole as detected at or above 40 ng/mL, and the method's reportable range is 40–1,600 ng/mL. A result below the cut-off is reported as not detected; it does not prove none was present.
The laboratory report does not print a standard window for Aripiprazole. Detection time varies with dose, frequency of use, metabolism and hydration.
Aripiprazole is not one of the 12 lines on the LabX 12-panel screen. It is identified by adding laboratory confirmation, which tests for all 76 compounds on the panel.
Aripiprazole is prescribed for schizophrenia, bipolar disorder, as an add-on treatment for depression, and for some other conditions.
Terms on this page: metabolite · cut-off · detection window · presumptive result · confirmation test. More questions: LabX answers.
Test for Aripiprazole and 75 other compounds
12-panel urine $89 or fingerstick blood $99, plus the 76-drug LC-MS/MS confirmation for +$89.
At-home drug tests and test kits are not currently available to addresses in New York, New Jersey, Rhode Island or California. Results are not a diagnosis — review them with a licensed physician.
Medical disclaimer. LabX Diagnostics and Vantage provide laboratory testing only. Test results and information on this site are for informational purposes and are not medical advice, diagnosis or treatment. Always consult a licensed physician or other qualified healthcare provider about your results and before making any health decision. If you think you may have a medical emergency, call 911. Read the full disclaimer.
Learn: 76-drug confirmation list · Drug library · Answers · How it works · Is LabX legit? · Glossary
